Fortress Biotech Sees Upgrades Amid Investor Shifts by Lilu Anderson 20.06.2024 "Fortress Biotech (FBIO) upgraded to 'Hold' by StockNews.com amid 5.8% decline; analysts offer mixed ratings as hedge funds increase stakes."